The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of cytoreduction, gastrectomy, and hyperthermic intraperitoneal perfusion with chemotherapy for patients with gastric cancer and stage IV peritoneal disease.
 
Brian D. Badgwell
No Relationships to Disclose
 
Naruhiko Ikoma
No Relationships to Disclose
 
Mariela A. Blum Murphy
Honoraria - EMD Serono; EMD Serono; EMD Serono; EMD Serono
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst)
 
Xuemei Wang
No Relationships to Disclose
 
Jeannelyn Estrella
No Relationships to Disclose
 
Sinchita Roy-Chowdhuri
No Relationships to Disclose
 
Prajnan Das
Consulting or Advisory Role - Adlai Nortye; Adlai Nortye; Adlai Nortye; Adlai Nortye
 
Bruce D. Minsky
Other Relationship - American Society for Radiation Oncology; American Society for Radiation Oncology; American Society for Radiation Oncology; American Society for Radiation Oncology; MD Anderson Physician’s Network; MD Anderson Physician’s Network; MD Anderson Physician’s Network; MD Anderson Physician’s Network
 
Paul F. Mansfield
Patents, Royalties, Other Intellectual Property - Royalties for up to date; Royalties for up to date; Royalties for up to date; Royalties for up to date
 
Jaffer A. Ajani
Honoraria - Aduro Biotech; Aduro Biotech; Aduro Biotech; Aduro Biotech; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck
Consulting or Advisory Role - American Cancer Society; American Cancer Society; American Cancer Society; American Cancer Society; BeiGene; BeiGene; BeiGene; BeiGene; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Insys Therapeutics; Insys Therapeutics; Insys Therapeutics; Insys Therapeutics; Merck; Merck; Merck; Merck; Vaccinogen; Vaccinogen; Vaccinogen; Vaccinogen
Research Funding - Amgen; Amgen; Amgen; Amgen; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Delta-Fly Pharma; Delta-Fly Pharma; Delta-Fly Pharma; Delta-Fly Pharma; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Lilly/ImClone; Lilly/ImClone; Lilly/ImClone; Lilly/ImClone; Merck; Merck; Merck; Merck; Novartis; Novartis; Novartis; Novartis; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Takeda; Takeda; Takeda; Takeda
Patents, Royalties, Other Intellectual Property - I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly; I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly; I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly; I have research funding from: Genentech, Roche, BMS, Taiho, MedImmune, Merck, Amgen, Lilly